Similar articles

• Gene therapy for genetic diseases.

  Kohn DB, Anderson WF, Blaese RM. Kohn DB, et al. Cancer Invest. 1989;7(2):179-92. doi: 10.3109/07357908909038283. Cancer Invest. 1989. PMID: 2676086 Review. No abstract available.
• Retroviral-mediated gene transfer into mammalian cells.

  Kohn DB, Kantoff PW, Eglitis MA, McLachlin JR, Moen RC, Karson E, Zwiebel JA, Nienhuis A, Karlsson S, O'Reilly R, et al. Kohn DB, et al. Blood Cells. 1987;13(1-2):285-98. Blood Cells. 1987. PMID: 3311223 Review.
• Novel strategies for the selection of cells expressing human adenosine deaminase and their application in experimental gene therapy protocols.

  Shen Q, Van Beusechem VW, Hendrikx PJ, Valerio D. Shen Q, et al. Allergol Immunopathol (Madr). 1991 Jan-Feb;19(1):29-31. Allergol Immunopathol (Madr). 1991. PMID: 1659164 No abstract available.
• Primary immunodeficiencies: molecular aspects and treatment.

  Fischer A. Fischer A. Bone Marrow Transplant. 1992;9 Suppl 1:39-43. Bone Marrow Transplant. 1992. PMID: 1354525 Review. No abstract available.
• Bone marrow gene therapy for adenosine deaminase deficiency.

  Kaptein LC, Einerhand MP, Braakman E, Valerio D, van Beusechem VW. Kaptein LC, et al. Immunodeficiency. 1993;4(1-4):335-45. Immunodeficiency. 1993. PMID: 7909479 Review.